Updated: March 25, 2021 BPOM approves COVID-19 drug Avifavir for emergency use Must Read Nationalindonesianupdates.com_admin - November 6, 2024President Prabowo seeks firm action against four crimes Nationalindonesianupdates.com_admin - November 6, 2024Expect substantial agreement from ICA-CEPA talks: trade ministry Nationalindonesianupdates.com_admin - November 6, 2024President Prabowo inks 47 regulations on ministries, agencies Indonesia’s Food and Drug Monitoring Agency (BPOM) has approved COVID-19 drug Avifavir for emergency use on coronavirus patients. “It’s true that BPOM has issued EUA for the product in question,” BPOM … Previous articleBNN cracks Malaysia-Madura drug ring; seizes over 87.4 kg drugsNext articleSeveral provinces to enter dry season in April, BMKG forecasts Latest News National - November 6, 2024President Prabowo seeks firm action against four crimesIndonesia's President Prabowo Subianto has urged law enforcement officers to take firm action against four major ... National Expect substantial agreement from ICA-CEPA talks: trade ministry - November 6, 2024 National President Prabowo inks 47 regulations on ministries, agencies - November 6, 2024 National President Prabowo awaiting US election results: spokesperson - November 6, 2024 National Indonesia eyes UNESCO recognition for three cultural heritages - November 6, 2024 More Articles Like This President Jokowi calls for a shift in defense policy BREAKING NEWS - October 5, 2021 Black & Veatch management consulting chosen to help drive SCG International’s electric vehicle transition in Thailand BREAKING NEWS - October 5, 2021 Australia successfully goes live With Everbridge Public Warning platform countrywide, representing official launch of the Australian Government’s next-generation national population alerting system BREAKING NEWS - October 5, 2021 PPKM outside Java-Bali extended till Oct 18 BREAKING NEWS - October 4, 2021
Indonesia’s Food and Drug Monitoring Agency (BPOM) has approved COVID-19 drug Avifavir for emergency use on coronavirus patients.